Playlist

Xi Jinping Congratulates Serdar Berdimuhamedov on His Birthday

22 Sep. 13:27

President of the People’s Republic of China, Xi Jinping, sent heartfelt birthday greetings to Turkmenistan’s President Serdar Berdimuhamedov, who turned 44 on September 22.

In his message, Xi extended sincere congratulations and best wishes to the Turkmen leader.

He noted Berdimuhamedov’s recent visit to China, during which he took part in the Shanghai Cooperation Organization (SCO) Summit and the 80th anniversary celebrations of China’s victory in the War of Resistance against Japan and the end of World War II.

Xi highlighted their fruitful meeting, where they had an in-depth exchange of views and reached broad consensus on further strengthening bilateral cooperation. He emphasized that these agreements lay a solid foundation for deepening the traditional friendship and mutually beneficial partnership between the two nations.

The Chinese leader reaffirmed his commitment to building a China–Turkmenistan Community with a Shared Future and wished President Berdimuhamedov good health and well-being.

‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌

Simple Vitamin Shows Surprising Results in Pre-Cancerous Blood Conditions, Study Finds

Today in 02:02

Source

Daily high-dose supplementation of vitamin C can significantly reduce mortality risks and help prevent severe medical complications in patients with pre-cancerous blood conditions. Researchers from the Van Andel Institute in the United States and Copenhagen University Hospital in Denmark reached this conclusion following a comprehensive three-year follow-up study. The international "EVITA" trial involved volunteers who were administered 1,000 mg of vitamin C daily over the course of a year, while a control group received a placebo.

Although initial hypotheses suggested vitamin C might directly inhibit abnormal cell proliferation, researchers found its primary benefit lay in strengthening the body, reducing systemic inflammation, and lowering rates of anemia, pneumonia, and internal bleeding. Over the three-year observation period, the vitamin C group exhibited a significantly higher survival rate compared to the placebo group. While experts emphasize that these findings remain preliminary and require larger clinical trials before reshaping formal medical treatment protocols, vitamin C continues to show promising potential in supportive patient care.

‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌